North American Star Consortium
$372,146UM1FY2022CANIH
University Health Network, Toronto ON
Investigators
Lillian L SiucontactPhilippe BedardKevin D CourtneySteven GrantSalma JabbourJeffrey LancetDevalingam Mahalingam
Linked publications, trials & patents
Paper 39379134Paper 38264947Paper 38206848Paper 37852935Paper 37659346Paper 37419999Paper 37380217Paper 36911757Paper 36864346Paper 36826995Paper 36780008Paper 35994691Paper 35989139Paper 35789025Paper 35264434Paper 35130943Paper 34417144Paper 34392779Paper 33811119Paper 33485453Paper 32996059Paper 32816943Paper 32804778Paper 32738099Paper 32676589Paper 32097505Paper 31992589Paper 31165047Paper 30561713Paper 28864727Paper 28864726Paper 28864723Paper 26686201Paper 26473189Paper 25682963Paper 25355929Paper 25318436Paper 25290091Paper 25160636Paper 25015668Paper 24938562Paper 24788563Paper 24048068Paper 23645447Trial NCT07012031Trial NCT05859334Trial NCT05564416Trial NCT05172245Trial NCT04963153Trial NCT04406857Trial NCT04090398Trial NCT04068194Trial NCT03856112Trial NCT03816358Trial NCT03816319Trial NCT03772925Trial NCT03587311Trial NCT03367741Trial NCT03345784Trial NCT03217253Trial NCT02862275Trial NCT02849496Trial NCT02589522Trial NCT02581930Trial NCT02568553Trial NCT02567396Trial NCT02520791Trial NCT02503722Trial NCT02498613Trial NCT02381548Trial NCT02381535Trial NCT02345265Trial NCT02339558Trial NCT02298959Trial NCT02275533Trial NCT02188264Trial NCT02101775Trial NCT02070549Trial NCT01989598Trial NCT01955499Trial NCT01935934Trial NCT01907802Trial NCT01783171Trial NCT01638533Trial NCT01548482Trial NCT01264432
Abstract
North American Star Consortium (NASC) (CA-UM186644) is consisted of Princess Margaret Cancer Centre- University Health Network (PM-UHN) as its Lead Academic Organization (LAO) and 5 Affiliated Organizations (AOs): H. Lee Moffitt Cancer Center, Virginal Commonwealth University, University of Texas Southwestern, Northwestern University and The State University of New Jersey at Rutgers. In the first two years of its UM1 grant, NASC has exceeded its accrual target of 100 patients per year by 38 participants. This administrative supplement enables the additional funding per participant for this over- accrual.
View original record on NIH RePORTER →